Filing Details
- Accession Number:
- 0001225208-13-017645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-12 16:11:40
- Reporting Period:
- 2013-08-08
- Filing Date:
- 2013-08-12
- Accepted Time:
- 2013-08-12 16:11:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400583 | C Eric Green | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2013-08-08 | 5,533 | $31.16 | 25,447 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2013-08-08 | 2,998 | $41.66 | 28,445 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2013-08-08 | 8,531 | $63.87 | 19,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-08 | 2,998 | $0.00 | 2,998 | $41.66 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-08-08 | 5,533 | $0.00 | 5,533 | $31.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-03-09 | No | 4 | M | Direct | |
| 0 | 2018-12-01 | No | 4 | M | Direct |
Footnotes
- Includes unvested restricted stock units and associated unvested dividend equivalent units, the number of which were adjusted in connection with the recent spin-off of Covidien's pharmaceuticals business.
- Shares sold pursuant to an existing Rule 10b5-1 trading plan.
- The price reported is a weighted average price. Shares were sold in two transactions at prices of $63.8600 and $63.8800. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- Options became exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
Billionaire Hedge Funds
